Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
49
TNXP Quote, Financials, Valuation and Earnings
Last price:
$19.52
Seasonality move
:
1.99%
Day range:
$17.74 - $20.03
52-week range:
$6.76 - $130.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
9.58x
P/B ratio:
0.57x
Volume:
1.1M
Avg. volume:
771.6K
1-year change:
12.24%
Market cap:
$130.8M
Revenue:
$10.1M
EPS (TTM):
-$986.99
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
TNXP
Tonix Pharmaceuticals Holding Corp.
|
$2.3M | -$2.75 | -18.5% | -90.25% | $67.67 |
|
EBS
Emergent BioSolutions, Inc.
|
$199M | -$0.12 | 11.71% | -94.67% | $13.50 |
|
GOVX
GeoVax Labs, Inc.
|
-- | -- | -100% | -- | $9.63 |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$3M | -$0.88 | 14.03% | -95.43% | $0.85 |
|
SIGA
SIGA Technologies, Inc.
|
-- | -- | -- | -- | -- |
|
VRTX
Vertex Pharmaceuticals, Inc.
|
$3.1B | $4.58 | 10.28% | 47.56% | $485.36 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
TNXP
Tonix Pharmaceuticals Holding Corp.
|
$17.78 | $67.67 | $130.8M | -- | $0.00 | 0% | 9.58x |
|
EBS
Emergent BioSolutions, Inc.
|
$12.05 | $13.50 | $632.9M | 9.31x | $0.00 | 0% | 0.85x |
|
GOVX
GeoVax Labs, Inc.
|
$0.38 | $9.63 | $11.4M | -- | $0.00 | 0% | 1.66x |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$1.06 | $0.85 | $133.6M | 1.78x | $0.80 | 0% | 2.06x |
|
SIGA
SIGA Technologies, Inc.
|
$6.24 | -- | $446.9M | 5.99x | $0.60 | 0% | 2.59x |
|
VRTX
Vertex Pharmaceuticals, Inc.
|
$463.13 | $485.36 | $117.5B | 32.64x | $0.00 | 0% | 10.23x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
TNXP
Tonix Pharmaceuticals Holding Corp.
|
0.18% | -3.103 | 0.24% | 9.28x |
|
EBS
Emergent BioSolutions, Inc.
|
53.53% | 4.454 | 144.36% | 2.93x |
|
GOVX
GeoVax Labs, Inc.
|
-- | 1.075 | -- | 2.75x |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
37.25% | 2.113 | 8.08% | 1.85x |
|
SIGA
SIGA Technologies, Inc.
|
0.43% | 1.632 | 0.13% | 7.02x |
|
VRTX
Vertex Pharmaceuticals, Inc.
|
9.58% | -0.151 | 1.84% | 1.84x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
TNXP
Tonix Pharmaceuticals Holding Corp.
|
$1.5M | -$33.1M | -61.13% | -62.54% | -1005.08% | -$31.5M |
|
EBS
Emergent BioSolutions, Inc.
|
$129.1M | $76.8M | 6.29% | 14.25% | 33.23% | -$5.7M |
|
GOVX
GeoVax Labs, Inc.
|
-$16.8K | -$6.4M | -433.69% | -433.69% | -635.8% | -$6.2M |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$42K | -$1.2M | -208.55% | -306.03% | -224.38% | -$1.8M |
|
SIGA
SIGA Technologies, Inc.
|
$1.6M | -$10.2M | 36.5% | 36.71% | -390.18% | -$10.1M |
|
VRTX
Vertex Pharmaceuticals, Inc.
|
$2.7B | $1.3B | 20.08% | 22.13% | 41.02% | $1.1B |
Tonix Pharmaceuticals Holding Corp. vs. Competitors
-
Which has Higher Returns TNXP or EBS?
Emergent BioSolutions, Inc. has a net margin of -972.95% compared to Tonix Pharmaceuticals Holding Corp.'s net margin of 22.16%. Tonix Pharmaceuticals Holding Corp.'s return on equity of -62.54% beat Emergent BioSolutions, Inc.'s return on equity of 14.25%.
Company Gross Margin Earnings Per Share Invested Capital TNXPTonix Pharmaceuticals Holding Corp.44.44% -$3.59 $231.6M EBSEmergent BioSolutions, Inc.55.86% $0.91 $1.3B -
What do Analysts Say About TNXP or EBS?
Tonix Pharmaceuticals Holding Corp. has a consensus price target of $67.67, signalling upside risk potential of 280.58%. On the other hand Emergent BioSolutions, Inc. has an analysts' consensus of $13.50 which suggests that it could grow by 12.03%. Given that Tonix Pharmaceuticals Holding Corp. has higher upside potential than Emergent BioSolutions, Inc., analysts believe Tonix Pharmaceuticals Holding Corp. is more attractive than Emergent BioSolutions, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TNXPTonix Pharmaceuticals Holding Corp.2 0 0 EBSEmergent BioSolutions, Inc.2 0 0 -
Is TNXP or EBS More Risky?
Tonix Pharmaceuticals Holding Corp. has a beta of 1.817, which suggesting that the stock is 81.674% more volatile than S&P 500. In comparison Emergent BioSolutions, Inc. has a beta of 2.318, suggesting its more volatile than the S&P 500 by 131.831%.
-
Which is a Better Dividend Stock TNXP or EBS?
Tonix Pharmaceuticals Holding Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Emergent BioSolutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tonix Pharmaceuticals Holding Corp. pays -- of its earnings as a dividend. Emergent BioSolutions, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TNXP or EBS?
Tonix Pharmaceuticals Holding Corp. quarterly revenues are $3.3M, which are smaller than Emergent BioSolutions, Inc. quarterly revenues of $231.1M. Tonix Pharmaceuticals Holding Corp.'s net income of -$32M is lower than Emergent BioSolutions, Inc.'s net income of $51.2M. Notably, Tonix Pharmaceuticals Holding Corp.'s price-to-earnings ratio is -- while Emergent BioSolutions, Inc.'s PE ratio is 9.31x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tonix Pharmaceuticals Holding Corp. is 9.58x versus 0.85x for Emergent BioSolutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TNXPTonix Pharmaceuticals Holding Corp.9.58x -- $3.3M -$32M EBSEmergent BioSolutions, Inc.0.85x 9.31x $231.1M $51.2M
-
Which has Higher Returns TNXP or GOVX?
GeoVax Labs, Inc. has a net margin of -972.95% compared to Tonix Pharmaceuticals Holding Corp.'s net margin of -630.04%. Tonix Pharmaceuticals Holding Corp.'s return on equity of -62.54% beat GeoVax Labs, Inc.'s return on equity of -433.69%.
Company Gross Margin Earnings Per Share Invested Capital TNXPTonix Pharmaceuticals Holding Corp.44.44% -$3.59 $231.6M GOVXGeoVax Labs, Inc.-- -$0.31 $4.9M -
What do Analysts Say About TNXP or GOVX?
Tonix Pharmaceuticals Holding Corp. has a consensus price target of $67.67, signalling upside risk potential of 280.58%. On the other hand GeoVax Labs, Inc. has an analysts' consensus of $9.63 which suggests that it could grow by 2409.12%. Given that GeoVax Labs, Inc. has higher upside potential than Tonix Pharmaceuticals Holding Corp., analysts believe GeoVax Labs, Inc. is more attractive than Tonix Pharmaceuticals Holding Corp..
Company Buy Ratings Hold Ratings Sell Ratings TNXPTonix Pharmaceuticals Holding Corp.2 0 0 GOVXGeoVax Labs, Inc.4 0 0 -
Is TNXP or GOVX More Risky?
Tonix Pharmaceuticals Holding Corp. has a beta of 1.817, which suggesting that the stock is 81.674% more volatile than S&P 500. In comparison GeoVax Labs, Inc. has a beta of 3.638, suggesting its more volatile than the S&P 500 by 263.848%.
-
Which is a Better Dividend Stock TNXP or GOVX?
Tonix Pharmaceuticals Holding Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. GeoVax Labs, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tonix Pharmaceuticals Holding Corp. pays -- of its earnings as a dividend. GeoVax Labs, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TNXP or GOVX?
Tonix Pharmaceuticals Holding Corp. quarterly revenues are $3.3M, which are larger than GeoVax Labs, Inc. quarterly revenues of --. Tonix Pharmaceuticals Holding Corp.'s net income of -$32M is lower than GeoVax Labs, Inc.'s net income of -$6.3M. Notably, Tonix Pharmaceuticals Holding Corp.'s price-to-earnings ratio is -- while GeoVax Labs, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tonix Pharmaceuticals Holding Corp. is 9.58x versus 1.66x for GeoVax Labs, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TNXPTonix Pharmaceuticals Holding Corp.9.58x -- $3.3M -$32M GOVXGeoVax Labs, Inc.1.66x -- -- -$6.3M
-
Which has Higher Returns TNXP or NBY?
NovaBay Pharmaceuticals, Inc. has a net margin of -972.95% compared to Tonix Pharmaceuticals Holding Corp.'s net margin of -255.85%. Tonix Pharmaceuticals Holding Corp.'s return on equity of -62.54% beat NovaBay Pharmaceuticals, Inc.'s return on equity of -306.03%.
Company Gross Margin Earnings Per Share Invested Capital TNXPTonix Pharmaceuticals Holding Corp.44.44% -$3.59 $231.6M NBYNovaBay Pharmaceuticals, Inc.8.06% -$0.22 $2.6M -
What do Analysts Say About TNXP or NBY?
Tonix Pharmaceuticals Holding Corp. has a consensus price target of $67.67, signalling upside risk potential of 280.58%. On the other hand NovaBay Pharmaceuticals, Inc. has an analysts' consensus of $0.85 which suggests that it could fall by -19.81%. Given that Tonix Pharmaceuticals Holding Corp. has higher upside potential than NovaBay Pharmaceuticals, Inc., analysts believe Tonix Pharmaceuticals Holding Corp. is more attractive than NovaBay Pharmaceuticals, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TNXPTonix Pharmaceuticals Holding Corp.2 0 0 NBYNovaBay Pharmaceuticals, Inc.1 0 0 -
Is TNXP or NBY More Risky?
Tonix Pharmaceuticals Holding Corp. has a beta of 1.817, which suggesting that the stock is 81.674% more volatile than S&P 500. In comparison NovaBay Pharmaceuticals, Inc. has a beta of 0.569, suggesting its less volatile than the S&P 500 by 43.103%.
-
Which is a Better Dividend Stock TNXP or NBY?
Tonix Pharmaceuticals Holding Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NovaBay Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.80 per share. Tonix Pharmaceuticals Holding Corp. pays -- of its earnings as a dividend. NovaBay Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TNXP or NBY?
Tonix Pharmaceuticals Holding Corp. quarterly revenues are $3.3M, which are larger than NovaBay Pharmaceuticals, Inc. quarterly revenues of $521K. Tonix Pharmaceuticals Holding Corp.'s net income of -$32M is lower than NovaBay Pharmaceuticals, Inc.'s net income of -$1.3M. Notably, Tonix Pharmaceuticals Holding Corp.'s price-to-earnings ratio is -- while NovaBay Pharmaceuticals, Inc.'s PE ratio is 1.78x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tonix Pharmaceuticals Holding Corp. is 9.58x versus 2.06x for NovaBay Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TNXPTonix Pharmaceuticals Holding Corp.9.58x -- $3.3M -$32M NBYNovaBay Pharmaceuticals, Inc.2.06x 1.78x $521K -$1.3M
-
Which has Higher Returns TNXP or SIGA?
SIGA Technologies, Inc. has a net margin of -972.95% compared to Tonix Pharmaceuticals Holding Corp.'s net margin of -242.97%. Tonix Pharmaceuticals Holding Corp.'s return on equity of -62.54% beat SIGA Technologies, Inc.'s return on equity of 36.71%.
Company Gross Margin Earnings Per Share Invested Capital TNXPTonix Pharmaceuticals Holding Corp.44.44% -$3.59 $231.6M SIGASIGA Technologies, Inc.61.75% -$0.09 $204.4M -
What do Analysts Say About TNXP or SIGA?
Tonix Pharmaceuticals Holding Corp. has a consensus price target of $67.67, signalling upside risk potential of 280.58%. On the other hand SIGA Technologies, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Tonix Pharmaceuticals Holding Corp. has higher upside potential than SIGA Technologies, Inc., analysts believe Tonix Pharmaceuticals Holding Corp. is more attractive than SIGA Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TNXPTonix Pharmaceuticals Holding Corp.2 0 0 SIGASIGA Technologies, Inc.0 0 0 -
Is TNXP or SIGA More Risky?
Tonix Pharmaceuticals Holding Corp. has a beta of 1.817, which suggesting that the stock is 81.674% more volatile than S&P 500. In comparison SIGA Technologies, Inc. has a beta of 0.980, suggesting its less volatile than the S&P 500 by 1.989%.
-
Which is a Better Dividend Stock TNXP or SIGA?
Tonix Pharmaceuticals Holding Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SIGA Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.60 per share. Tonix Pharmaceuticals Holding Corp. pays -- of its earnings as a dividend. SIGA Technologies, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TNXP or SIGA?
Tonix Pharmaceuticals Holding Corp. quarterly revenues are $3.3M, which are larger than SIGA Technologies, Inc. quarterly revenues of $2.6M. Tonix Pharmaceuticals Holding Corp.'s net income of -$32M is lower than SIGA Technologies, Inc.'s net income of -$6.4M. Notably, Tonix Pharmaceuticals Holding Corp.'s price-to-earnings ratio is -- while SIGA Technologies, Inc.'s PE ratio is 5.99x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tonix Pharmaceuticals Holding Corp. is 9.58x versus 2.59x for SIGA Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TNXPTonix Pharmaceuticals Holding Corp.9.58x -- $3.3M -$32M SIGASIGA Technologies, Inc.2.59x 5.99x $2.6M -$6.4M
-
Which has Higher Returns TNXP or VRTX?
Vertex Pharmaceuticals, Inc. has a net margin of -972.95% compared to Tonix Pharmaceuticals Holding Corp.'s net margin of 34.76%. Tonix Pharmaceuticals Holding Corp.'s return on equity of -62.54% beat Vertex Pharmaceuticals, Inc.'s return on equity of 22.13%.
Company Gross Margin Earnings Per Share Invested Capital TNXPTonix Pharmaceuticals Holding Corp.44.44% -$3.59 $231.6M VRTXVertex Pharmaceuticals, Inc.86.69% $4.20 $19.2B -
What do Analysts Say About TNXP or VRTX?
Tonix Pharmaceuticals Holding Corp. has a consensus price target of $67.67, signalling upside risk potential of 280.58%. On the other hand Vertex Pharmaceuticals, Inc. has an analysts' consensus of $485.36 which suggests that it could grow by 4.8%. Given that Tonix Pharmaceuticals Holding Corp. has higher upside potential than Vertex Pharmaceuticals, Inc., analysts believe Tonix Pharmaceuticals Holding Corp. is more attractive than Vertex Pharmaceuticals, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TNXPTonix Pharmaceuticals Holding Corp.2 0 0 VRTXVertex Pharmaceuticals, Inc.18 10 1 -
Is TNXP or VRTX More Risky?
Tonix Pharmaceuticals Holding Corp. has a beta of 1.817, which suggesting that the stock is 81.674% more volatile than S&P 500. In comparison Vertex Pharmaceuticals, Inc. has a beta of 0.318, suggesting its less volatile than the S&P 500 by 68.249%.
-
Which is a Better Dividend Stock TNXP or VRTX?
Tonix Pharmaceuticals Holding Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Vertex Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tonix Pharmaceuticals Holding Corp. pays -- of its earnings as a dividend. Vertex Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TNXP or VRTX?
Tonix Pharmaceuticals Holding Corp. quarterly revenues are $3.3M, which are smaller than Vertex Pharmaceuticals, Inc. quarterly revenues of $3.1B. Tonix Pharmaceuticals Holding Corp.'s net income of -$32M is lower than Vertex Pharmaceuticals, Inc.'s net income of $1.1B. Notably, Tonix Pharmaceuticals Holding Corp.'s price-to-earnings ratio is -- while Vertex Pharmaceuticals, Inc.'s PE ratio is 32.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tonix Pharmaceuticals Holding Corp. is 9.58x versus 10.23x for Vertex Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TNXPTonix Pharmaceuticals Holding Corp.9.58x -- $3.3M -$32M VRTXVertex Pharmaceuticals, Inc.10.23x 32.64x $3.1B $1.1B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 5
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
38
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
69
ASTS alert for Dec 5
AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.
